Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12371666 | Nucleoside modified mRNA and uses thereof | Valerie Gouon-Evans, Norbert Pardi | 2025-07-29 |
| 12364750 | Conserved region T cell vaccines for coronavirus and methods of use | Bette T. Korber, James Theiler, Dan H. Barouch, Tomas Hanke | 2025-07-22 |
| 12226471 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | George M. Shaw, Justin R. Bailey, Stuart C. Ray, James E. Crowe, Jr., Andrew Flyak | 2025-02-18 |
| 12161709 | Compositions for inducing an immune response against zika virus | Norbert Pardi, Michael E. Hogan | 2024-12-10 |
| 12138305 | Nucleoside-modified RNA for inducing an adaptive immune response | Norbert Pardi | 2024-11-12 |
| 12054734 | Purification and purity assessment of RNA molecules synthesized with modified nucleosides | Katalin Kariko | 2024-08-06 |
| 12023376 | Conserved region T cell vaccines for coronavirus and methods of use | Bette T. Korber, James Theiler, Dan H. Barouch, Tomas Hanke | 2024-07-02 |
| 11801314 | RNA containing modified nucleosides and methods of use thereof | Katalin Kariko | 2023-10-31 |
| 11793872 | Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof | Harvey Friedman, Sita Awasthi, Gary H. Cohen | 2023-10-24 |
| 11739300 | RNA preparations comprising purified modified RNA for reprogramming cells | Katalin Kariko, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak | 2023-08-29 |
| 11660332 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | George M. Shaw, Justin R. Bailey, Stuart C. Ray, James E. Crowe, Jr., Andrew Flyak | 2023-05-30 |
| 11389547 | RNA containing modified nucleosides and methods of use thereof | Katalin Kariko | 2022-07-19 |
| 11241490 | Nucleoside-modified RNA for inducing an immune response against zika virus | Norbert Pardi, Michael E. Hogan | 2022-02-08 |
| 11141478 | Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof | Harvey Friedman, Sita Awasthi, Gary H. Cohen | 2021-10-12 |
| 11060107 | Purification and purity assessment of RNA molecules synthesized with modified nucleosides | Katalin Kariko | 2021-07-13 |
| 11028370 | RNA preparations comprising purified modified RNA for reprogramming cells | Katalin Kariko, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak | 2021-06-08 |
| 10232055 | RNA containing modified nucleosides and methods of use thereof | Katalin Kariko | 2019-03-19 |
| 10006007 | RNA preparations comprising purified modified RNA for reprogramming cells | Katalin Kariko, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak | 2018-06-26 |
| 9750824 | RNA containing modified nucleosides and methods of use thereof | Katalin Kariko | 2017-09-05 |
| 9580473 | Method of inhibiting HIV-1 binding to genital epithelia using V3 loop-specific peptides and GP340-specific antibodies | Earl Stoddard | 2017-02-28 |
| 9371511 | RNA preparations comprising purified modified RNA for reprogramming cells | Katalin Kariko, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak | 2016-06-21 |
| 9163213 | RNA preparations comprising purified modified RNA for reprogramming cells | Katalin Kariko, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak | 2015-10-20 |
| 9012219 | RNA preparations comprising purified modified RNA for reprogramming cells | Katalin Kariko, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak | 2015-04-21 |
| 8835108 | RNA containing modified nucleosides and methods of use thereof | Katalin Kariko | 2014-09-16 |
| 8748089 | RNA containing modified nucleosides and methods of use thereof | Katalin Kariko | 2014-06-10 |